Vanderbilt quarterback Diego Pavia is taking responsibility for the ‘disrespectful’ behavior he exhibited after losing the Heisman Trophy to Indiana quarterback Fernando Mendoza. After finishing in ...

He was an architect with no training as an actor whose life was changed by a chance encounter. He inspired rave reviews and a New Yorker short story. By Alex Traub Homayoun Ershadi, a middle-aged ...

Iranian actor Homayoun Ershadi, known for his work in films like ‘Taste of Cherry’ and ‘The Kite Runner’, has passed away at the age of 78 after a battle with cancer. The news has left fans and ...

Homayoun Ershadi, the Iranian architect-turned-actor who is best known internationally for his role in Marc Forster’s Afghanistan-set The Kite Runner, has died at the age of 78. Iran’s state news ...

Shewarge Alene, who won the women’s race in May at the Stockholm Marathon, has died at the age of 30 after becoming ill. Officials with the Stockholm Marathon released a statement online saying Alene ...

The Kite Loft's 47th annual Sunfest Kite Festival will take place in Ocean City, Maryland, from September 18-21, 2025. The festival will feature a variety of uniquely shaped kites, including dragons, ...

Julio is a Senior Author for Collider. He studied History and International Relations at university, but found his calling in cultural journalism. When he isn't writing, Julio also teaches English at ...

Blade Runner’s third live-action entry will be a streaming miniseries on Amazon Prime Video, and Deadline reports that it is now slated for release in 2026. “The update was provided by Laura Lancaster ...

AT SIX. AND NEW AT SIX. A KITESURFER RESCUED OFF GRAVES LIGHT AND A CHANCE ENCOUNTER SAVED HIS LIFE. LET’S GET TO NEWSCENTER 5 JOHN ATWATER. HE SPOKE WITH HIM. HE JOINS US LIVE FROM EAST BOSTON RIGHT ...

The wait is almost over. Blade Runner 2099, Prime Video‘s limited series followup to the 2017 movie sequel Blade Runner 2049, will premiere on the platform in 2026. The update was provided by Laura ...

Gilead Sciences has become the latest pharma to strengthen its in vivo cell therapy credentials this year, paying $350 million for CAR-T developer Interius BioTherapeutics. Integrating Interius into ...